Impact of Cervical Cancer Screening Guidelines on Screening for Chlamydia.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 26195682.
- Also identified by DOI 10.1370/afm.1811 and PMC identifier 4508178.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The highest prevalence of chlamydia infection in the United States is among people aged 15 to 24 years. We assessed the impact of not doing routine cervical cancer screening on the rates of chlamydia screening in women aged 15 to 21 years. We classified visits to family medicine ambulatory clinics according to their timing relative to the 2009 guideline change that led to more restrictive cervical cancer screening. Women had higher odds of being screened for chlamydia before vs after the guideline change (odds ratio = 13.97; 95% CI, 9.17-21.29; P <.001). Chlamydia and cervical cancer screening need to be uncoupled and new screening opportunities should be identified.
Medical subject headings
- Chlamydia Infections
- Mass Screening